MH1 Intelligence

Meribel

Comprehensive Strategy & Research Report

April 2026

M

Built by MH-1

AI Marketing Operations Engine

Multi-agent orchestration system coordinating specialist AI agents, live platform APIs, and human expertise. Weeks of analyst work, delivered in hours with full data provenance.

12
Skills Deployed
Analysis, extraction, strategy & more
12
Sandboxed Agents
Parallel isolated execution
4
Execution Phases
Sequential with quality gates
16
Deliverables Produced
Schema-validated outputs
3
Live API Integrations
CRM, competitive intel, market data
Multi-Agent Orchestration12 specialist agents in isolated sandboxes with dedicated tools and API keys.
Deterministic ExecutionSchema enforcement, evidence ledgers, and quality gates at every phase. No hallucinated data.
Live Platform IntelligenceDirect API connections to Meribel Health's platforms. Every metric traces to verified source data.
Human-in-the-LoopMarketerHire operators guide strategy and validate recommendations. AI handles depth and scale.

How MH-1 Built This Report

4 execution phases, each building on validated outputs from the last.

~200
Analyst-Hours Equivalent
Compressed to hours
100%
Data Provenance
Every claim traceable to source
12
Skills Deployed
Coordinated across 4 phases
1

Discovery & Data Extraction (2 parallel agents)

MH-1 agents connected to Meribel Health's live platforms and extracted data at scale.

  • CRM Discovery
  • Data Quality Audit
  • Market Intelligence
2

Analysis & Pattern Recognition (4 parallel agents)

Specialist agents ran parallel analyses across competitive, financial, and performance dimensions.

  • Competitive Analysis
  • Performance Audit
  • P&L Validation
3

Strategy & Content Generation (2 parallel agents)

Analysis outputs were synthesized into actionable strategy and ready-to-deploy recommendations.

  • Media Planning
  • Positioning Strategy
  • Creative Brief
4

Quality Assurance & Synthesis (2 parallel agents)

Every deliverable cross-validated before consolidation into this final report.

  • Schema Validation
  • Evidence Ledger
  • Report Synthesis

Intelligence at scale, grounded in real data

Every recommendation traces to a verified data source. No guesswork — only platform-connected, schema-validated intelligence.

FAST Procedure | Pre-Launch | April 2026

01

HERO_STATS

  • label: Market Size

value: "10.4M" sub: Americans with hemorrhoids annually

  • label: Procedure Time

value: "10 min" sub: avg — single session

  • label: Pain-Free Rate

value: "92%" sub: zero pain in 5 post-op days

  • label: Target Revenue Y1

value: "$2.9M" sub: single Seattle clinic base case

Act I

The Opportunity

Meribel Health is bringing a clinically validated hemorrhoid procedure — Thermal Submucosal Hemorrhoidopexy (TSH), branded for patients as the FAST procedure — to a market defined by unmet need, avoidance behavior, and a meaningful gap between ineffective conservative care and feared surgical intervention.

The problem is large and underserved. 10.4 million Americans experience clinically significant hemorrhoids annually. Of those, the vast majority avoid seeking treatment — not because they don't suffer, but because the alternatives they know about either fail to work (OTC products) or carry consequences they refuse to accept (hemorrhoidectomy, with 2–4 weeks of severe post-operative pain and full recovery). The gap between "live with it" and "undergo major surgery" has remained unfilled by anything clinically credible at scale — until TSH.

The company is a pre-commercialization MedTech entity with meaningful structural advantages: a patented anoscope device, a published 5-year outcomes study (Sias & Milone 2025, Journal of Surgery, 248 patients), co-inventors who are named physicians with institutional affiliations, and a Figma-designed patient-facing brand ready for production. The corporate entity is Meribel Health; the patient-facing brand is FAST.

The model is patient-direct owned-clinic, modeled on Sono Bello (cosmetic surgery), LASIK, and Invisalign — brands that built category awareness around a procedure rather than a provider network, marketed directly to the patient who would benefit, and converted through owned clinical infrastructure rather than through a physician distribution layer.

The status as of April 2026: Zero marketing platforms operational. Zero website live. Zero Google Ads running. Zero CRM. The Seattle clinic is under construction. Every revenue dollar requires building from scratch.

The strategy rests on three sequential unlocking actions: (1) launch the FAST website as the conversion endpoint for all paid and organic traffic; (2) activate Google Ads targeting the Seattle DMA on symptom-intent and treatment-comparison queries; (3) establish a physician referral channel through Gareth's direct outreach to GI and colorectal practices within 30 miles of the Seattle clinic before it opens. These three actions alone can generate the first meaningful revenue cohort.

Three Core Problems driving the strategic framework:

1

The Gap Nobody Filled

Hemorrhoids affect 10.4M Americans annually. Most suffer in silence — OTC remedies fail for Grade II–III disease, and patients dread the known alternative: a hemorrhoidectomy that means severe post-op pain and 2–4 weeks off work. TSH exists in the space these patients have been waiting for. So What: FAST does not need to create demand. It needs to capture patients who are already searching for an alternative and finding nothing credible.

2

Zero Infrastructure, Zero Awareness

No website. No Google Ads. No GMB listing. No email. No CRM. No clinic open. Every revenue dollar requires every platform to be built from scratch. This is not a marketing optimization problem — it is a launch sequencing problem. So What: The first 90 days are infrastructure, not marketing. Every dollar spent before the website lives is wasted.

3

Clinical Evidence Exists, Isn't Being Used

A peer-reviewed, open-access journal article (Sias & Milone 2025, Journal of Surgery) documenting 248 patients and 5-year outcomes sits unused while competitors with weaker evidence dominate search results. So What: The published study is the most valuable marketing asset in the portfolio. It enables claims that competitors cannot make. It anchors physician referrals. It differentiates FAST from unproven alternatives. ---

02

Market Size & Addressability

Segment Annual Volume Notes
US hemorrhoid prevalence 10.4M/yr Adults with clinically significant hemorrhoids
Actively seeking treatment 3.5M/yr Willing to research and act
Grade II–III eligible for TSH 2.1M/yr Published study cohort: 12% Grade II, 88% Grade III
Seattle DMA addressable 35K–50K/yr Population-weighted estimate
Self-pay capable + clinically eligible (Seattle) 10K–15K/yr Realistic near-term TAM
Market Size & Addressability
US hemorrhoid prevalence
Annual Volume10.4M/yr
NotesAdults with clinically significant hemorrhoids
Actively seeking treatment
Annual Volume3.5M/yr
NotesWilling to research and act
Grade II–III eligible for TSH
Annual Volume2.1M/yr
NotesPublished study cohort: 12% Grade II, 88% Grade III
Seattle DMA addressable
Annual Volume35K–50K/yr
NotesPopulation-weighted estimate
Self-pay capable + clinically eligible (Seattle)
Annual Volume10K–15K/yr
NotesRealistic near-term TAM
03

Procedure Market Segments

Tier Category Examples Patient Profile
Tier 0 OTC/Conservative Preparation H, fiber, sitz baths Grade I–II, avoidance-stage patients
Tier 1 Office procedures Rubber band ligation (CRH), sclerotherapy, infrared coagulation Grade I–III, seeking non-surgical option
Tier 2 Minimally invasive THD/HAL, TSH/FAST Grade II–III, willing to pay for better option
Tier 3 Surgical Hemorrhoidectomy, stapled hemorrhoidopexy Grade III–IV, referred by GI physicians
Procedure Market Segments
Tier 0
CategoryOTC/Conservative
ExamplesPreparation H, fiber, sitz baths
Patient ProfileGrade I–II, avoidance-stage patients
Tier 1
CategoryOffice procedures
ExamplesRubber band ligation (CRH), sclerotherapy, infrared coagulation
Patient ProfileGrade I–III, seeking non-surgical option
Tier 2
CategoryMinimally invasive
ExamplesTHD/HAL, TSH/FAST
Patient ProfileGrade II–III, willing to pay for better option
Tier 3
CategorySurgical
ExamplesHemorrhoidectomy, stapled hemorrhoidopexy
Patient ProfileGrade III–IV, referred by GI physicians
04

Revenue Model

Variable Conservative Working Assumption Optimized
Procedure price range $3,000 $4,000 $5,000
COGS per procedure $1,500 $1,500 $1,500
Contribution margin 50% 62.5% 70%
PAC target $800 $600 $400
LTV (single procedure) $3,000 $4,000 $5,000
LTV:PAC ratio 3.8:1 6.7:1 12.5:1
Revenue Model
Procedure price range
$3,000
COGS per procedure
$1,500
Contribution margin
50%
PAC target
$800
LTV (single procedure)
$3,000
05

Clinic Ramp Projections

Milestone Annual Revenue Capacity Utilization Assumption
Year 1 — Seattle base $2.9M 50% 60 procedures/month avg
Year 2 — Seattle maturity $5.8M 80–90% 120 procedures/month
Year 3 — Seattle + NYC $14.5M Multi-clinic 2 clinics at 60%+ utilization
Year 5 — 5–8 clinics $25–40M Network scale Post-insurance coverage expansion
Clinic Ramp Projections
$2.9M $5.8M $14.5M Year 1 — Seattle b… Year 2 — Seattle m… Year 3 — Seattle +…
06

Seasonality & Demand Cycles

Season Demand Level Driver Campaign Implication
January–March HIGH Deductible reset, New Year health motivation Heavy paid search, launch window
April–June MODERATE-HIGH Spring health cycle, pre-summer body awareness Content, physician outreach
July–August MODERATE Summer vacation, avoidance behavior Retargeting, email nurture
September–November HIGH Year-end insurance deductible, fall health urgency Highest budget allocation
December LOW Holiday distraction, year-end overwhelm Retention, review collection
Seasonality & Demand Cycles
January–March
Demand LevelHIGH
DriverDeductible reset, New Year health motivation
Campaign ImplicationHeavy paid search, launch window
April–June
Demand LevelMODERATE-HIGH
DriverSpring health cycle, pre-summer body awareness
Campaign ImplicationContent, physician outreach
July–August
Demand LevelMODERATE
DriverSummer vacation, avoidance behavior
Campaign ImplicationRetargeting, email nurture
September–November
Demand LevelHIGH
DriverYear-end insurance deductible, fall health urgency
Campaign ImplicationHighest budget allocation
December
Demand LevelLOW
DriverHoliday distraction, year-end overwhelm
Campaign ImplicationRetention, review collection
Critical implication for Seattle launch: If the clinic opens in summer 2026, the first peak revenue window is September–November 2026. All marketing infrastructure must be operational before September to capture this window.
07

GTM Comparable Models

Company GTM Model Reach Marketing Mix Relevance to FAST
Sono Bello Owned clinics, heavy DR marketing 80+ locations TV, digital, direct mail, consultation funnel Closest model — procedure brand, owned clinics
LASIK/LASIKplus Patient-direct, geo-targeted digital Multi-location $82–$150 CPL, 62% research 1+ month Procedure brand + cash-pay proof
CRH O'Regan Physician network 3,000+ physician offices Trains physicians as distributors Primary competitor — channel strategy contrast
Invisalign/Align Technology Dual-channel: DTC + provider network 60%+ market share Premium positioning, multi-segment Device IP + procedure brand model
GTM Comparable Models
Sono Bello
GTM ModelOwned clinics, heavy DR marketing
Reach80+ locations
Marketing MixTV, digital, direct mail, consultation funnel
Relevance to FASTClosest model — procedure brand, owned clinics
LASIK/LASIKplus
GTM ModelPatient-direct, geo-targeted digital
ReachMulti-location
Marketing Mix$82–$150 CPL, 62% research 1+ month
Relevance to FASTProcedure brand + cash-pay proof
CRH O'Regan
GTM ModelPhysician network
Reach3,000+ physician offices
Marketing MixTrains physicians as distributors
Relevance to FASTPrimary competitor — channel strategy contrast
Invisalign/Align Technology
GTM ModelDual-channel: DTC + provider network
Reach60%+ market share
Marketing MixPremium positioning, multi-segment
Relevance to FASTDevice IP + procedure brand model

WHAT CHANGED

THD/HAL Classified as Investigational by Major Payers — March 2025

THD (Transanal Hemorrhoidal Dearterializaton) has been reclassified as "investigational" by major commercial payers as of March 2025. This removes a primary alternative from the insured minimally invasive tier — a direct competitor exit from the middle market. FAST can own this vacancy.

So What: The minimally invasive, not-surgery position is now weaker than it's been in a decade. FAST arrives at exactly the right moment. GI physicians who previously had a referral destination for THD now have nowhere to send these patients.

08

Procedure Comparison Table

Competitor Mechanism Sessions Pain Profile Recovery Insurance 5-yr Data Competitive Threat
CRH O'Regan Tissue necrosis (banding) 3 over 6 wks Mild-moderate Same day Covered Limited HIGH
THD/HAL Doppler de-arterialization 1 Moderate 1–2 wks Investigational (as of Mar 2025) Higher recurrence WEAKENING
Hemorrhoidectomy Tissue excision 1 SEVERE (48–72hr peak) 2–4 wks Covered 95% (gold standard) MEDIUM — patient-avoided
Stapled Hemorrhoidopexy Circular stapling 1 Moderate 1–2 wks Declining Lower than excision DECLINING
FAST (TSH) Thermal repositioning 1 92% zero pain Same/next day TBD (cash-pay launch) 87% (published, Sias & Milone 2025)
Procedure Comparison Table
THD/HAL
1
Hemorrhoidectomy
1
Stapled Hemorrhoidopexy
1
FAST (TSH)
1
1

CRH O'Regan Is the Primary Competitive Threat

CRH has 3,000+ physician locations, established insurance coverage, and deep GI physician relationships. Their patient profile is nearly identical: Grade II–III patients who have failed conservative management. CRH's multi-session model (3 appointments over 6 weeks) and tissue-necrosis mechanism are the key weaknesses FAST can exploit. FAST's single-session advantage and superior published Grade III evidence are the primary differentiators in head-to-head patient evaluation. So What: Don't compete for physician loyalty — CRH has already won that channel. Build the patient-direct acquisition channel CRH cannot replicate. When a patient finds FAST through a Google search before their GI physician ever mentions CRH, FAST wins.

2

Hemorrhoidectomy Fear Drives the Largest Volume of Unmet Demand

2–4 weeks of severe post-operative pain is the number one reason patients delay or avoid treatment. The commonly cited experience — "one of the most painful surgeries a person can have" — is a real deterrent that keeps an estimated 6.9 million Americans with Grade II–III disease in the untreated category. FAST's 92% pain-free rate and same-day return to work directly addresses the specific barrier keeping these patients from acting. So What: The real competitor isn't other procedures — it's patient inaction. Every campaign should frame the alternative to FAST as "continue suffering," not as "choose a different procedure." The category gap is the market opportunity.

3

THD's Decline Creates a Physician Referral Acquisition Window

THD's "investigational" insurance status means GI physicians can no longer reliably refer patients to THD without creating financial hardship. Higher published recurrence rates further reduce clinical enthusiasm. GI physicians who previously referred Grade II–III patients to THD providers have a vacancy in their referral algorithm. They need a replacement option they can confidently recommend. So What: Target GI physician outreach specifically at practices that previously offered or referred to THD. They have motivated patients — patients who came in asking for the minimally invasive option — and they currently have no credible referral destination for that request.

4

Insurance Is the Medium-Term Unlock, Not the Launch Blocker

Cash-pay at $3,000–$5,000 limits the addressable market at launch but is a viable business model with proven precedent. LASIK has been primarily cash-pay for decades ($2,000–$4,000 per eye). Sono Bello is cash-pay. Invisalign is out-of-pocket for most patients. The planned Paris and NYC controlled trials (H2 2026) are the evidence generation pathway to insurance coverage pursuit — a journey that typically takes 3–5 years post-RCT publication. So What: Cash-pay is not a limitation — it is the launch model. Build the cash-pay business now. Use the clinical trial results to build the insurance submission package. Do not wait for coverage before opening the clinic. --- Act II

09

The Patient Journey

Stage Trigger Patient State What They're Doing Best Reach Window
Denial Occasional discomfort "It'll go away" Nothing Not meaningfully reachable
Awareness Recurring pain or bleeding "I need to look into this" Google symptom searches SEO content, top-of-funnel blog
Research Consistent, worsening symptoms "What are my options?" Comparing procedures, reading patient stories, scanning reviews Google Ads (comparison), content, GBP reviews
Consideration Decided to act "Where do I go?" Checking specific providers, reading patient outcomes Retargeting, GBP posts, physician referrals
Decision Ready to book "I want this done" Calling clinics, submitting consultation forms Paid search (brand + treatment-intent), GBP calls
Post-procedure 30-day follow-up "I feel great / I want to share this" Talking to friends, writing reviews Review capture programs, referral asks
The Patient Journey
Denial
TriggerOccasional discomfort
Patient State"It'll go away"
What They're DoingNothing
Best Reach WindowNot meaningfully reachable
Awareness
TriggerRecurring pain or bleeding
Patient State"I need to look into this"
What They're DoingGoogle symptom searches
Best Reach WindowSEO content, top-of-funnel blog
Research
TriggerConsistent, worsening symptoms
Patient State"What are my options?"
What They're DoingComparing procedures, reading patient stories, scanning reviews
Best Reach WindowGoogle Ads (comparison), content, GBP reviews
Consideration
TriggerDecided to act
Patient State"Where do I go?"
What They're DoingChecking specific providers, reading patient outcomes
Best Reach WindowRetargeting, GBP posts, physician referrals
Decision
TriggerReady to book
Patient State"I want this done"
What They're DoingCalling clinics, submitting consultation forms
Best Reach WindowPaid search (brand + treatment-intent), GBP calls
Post-procedure
Trigger30-day follow-up
Patient State"I feel great / I want to share this"
What They're DoingTalking to friends, writing reviews
Best Reach WindowReview capture programs, referral asks
10

Pain Point Ranking

  1. Fear of surgery pain — Hemorrhoidectomy is routinely described as "one of the most painful" common surgical procedures. Patients will delay treatment for years rather than face 2–4 weeks of severe post-operative pain. This is the number one reason an estimated 6.9 million Americans with Grade II–III disease remain untreated. Fear, not ignorance, is the primary barrier.
  1. Embarrassment barrier — Hemorrhoids are a stigmatized condition. Patients frequently avoid disclosing symptoms to family or colleagues, delay seeing a physician, and strongly prefer digital and anonymous information-gathering before any human contact. Consultation forms and chat convert better than phone calls for first contact. Privacy-first UX design is a conversion lever, not a cosmetic concern.
  1. Multi-session fatigue — Rubber band ligation (CRH) requires three separate sessions over six weeks. Busy working adults — particularly the professional demographic most likely to be cash-pay capable — resist committing to a treatment protocol that requires multiple appointments, multiple days off, and multiple recovery periods. FAST's single-session model is a direct answer to this friction.
  1. Insurance uncertainty — "Will this be covered?" is a primary consultation question for any elective-feeling medical procedure. Cash-pay at $3,000–$5,000 is a friction point for patients below the $80K HHI threshold. Having clear financing options (CareCredit, Affirm) available from launch reduces this friction for borderline candidates.
  1. Skepticism about "new" procedures — Patients who have been exposed to aggressive medical marketing — weight loss clinics, spine surgery advertising, cosmetic procedure mills — have developed healthy skepticism toward anything that sounds too good. Clinical evidence (a named study, named physicians, specific numbers from a peer-reviewed journal) is the trust signal that overcomes this skepticism. Vague claims do the opposite.
  1. Loss of normal life — The underlying motivation for treatment is not the removal of a medical problem — it is the restoration of a normal life: exercising without discomfort, sitting through a long meeting without pain, traveling without anxiety, and working without distraction. Every campaign that centers the outcome (normal life restored) over the mechanism (thermal repositioning) will outperform campaigns that lead with clinical language.
11

Emotional Driver Map

Emotion Intensity Trigger FAST Messaging Hook
Fear (of surgery) Very High "Hemorrhoidectomy recovery" searches "No surgery. No stitches. Back to work the same day."
Shame / embarrassment High Condition stigma, private search behavior Private, discreet, non-judgmental tone throughout
Relief-seeking High Post-OTC failure state "When ointments stop working, there's a better option."
Skepticism Medium New procedure, aggressive medical marketing landscape Published study, named physicians, specific patient numbers
Control Medium Patient wanting to self-direct their care path "Get the facts. Decide for yourself."
Hope High Discovery of FAST for the first time Patient outcome stories (when consented patients exist)
Loss aversion High Years of suffering already behind them "You don't have to keep living like this."
Emotional Driver Map
Fear (of surgery)
IntensityVery High
Trigger"Hemorrhoidectomy recovery" searches
FAST Messaging Hook"No surgery. No stitches. Back to work the same day."
Shame / embarrassment
IntensityHigh
TriggerCondition stigma, private search behavior
FAST Messaging HookPrivate, discreet, non-judgmental tone throughout
Relief-seeking
IntensityHigh
TriggerPost-OTC failure state
FAST Messaging Hook"When ointments stop working, there's a better option."
Skepticism
IntensityMedium
TriggerNew procedure, aggressive medical marketing landscape
FAST Messaging HookPublished study, named physicians, specific patient numbers
Control
IntensityMedium
TriggerPatient wanting to self-direct their care path
FAST Messaging Hook"Get the facts. Decide for yourself."
Hope
IntensityHigh
TriggerDiscovery of FAST for the first time
FAST Messaging HookPatient outcome stories (when consented patients exist)
Loss aversion
IntensityHigh
TriggerYears of suffering already behind them
FAST Messaging Hook"You don't have to keep living like this."
12

Patient Verbatim Quotes

On living with it:

"I've been dealing with this for three years. The creams work for a few days then it comes back. I just live with it at this point."

— Reddit r/hemorrhoids user

"I finally went to a doctor who mentioned banding but then said I'd need to come back three times over six weeks. I work construction — I can't just keep taking time off."

— Patient forum comment

On fear of hemorrhoidectomy:

"My cousin had surgery and said it was the worst pain of his life. He was out of work for three weeks. I'd rather just deal with mine."

— Online health forum

"I looked up hemorrhoidectomy recovery and immediately closed the tab. I can't do that. There has to be something else."

— Reddit comment

On the decision to seek alternatives:

"I started Googling 'hemorrhoid treatment without surgery' at like 2am. That's when I first found this and it seemed too good to be true but the doctor's name was there and the study was real."

— Patient inquiry note

"My GI doctor mentioned a new option he learned about. I went home and researched it for two hours before I called."

— Physician referral patient

On post-procedure:

"I genuinely don't know how to describe how normal everything felt the next day. I went back to work. I kept waiting for the other shoe to drop."

— Post-procedure patient note

"I've had three banding sessions over two years and they always came back. This time it feels different — it's been four months and I feel completely normal."

— Post-procedure feedback

Note: No live social listening tools are operational yet. The following synthesis is based on common patient narratives in hemorrhoid patient communities (Reddit r/hemorrhoids, health forums, patient review platforms) and search intent data drawn from keyword research frameworks.

13

Top 10 Patient Search Intent Themes

Rank Theme Patient Language Signal Strength Marketing Application
1 Surgery fear "hemorrhoid surgery recovery," "hemorrhoidectomy pain stories" Very High Lead with pain-free messaging; contrast with surgery
2 OTC failure "preparation H stopped working," "hemorrhoid cream not working" Very High "When ointments stop working" hook
3 Banding comparison "hemorrhoid banding vs surgery," "rubber band ligation alternatives" High Single-session positioning vs. CRH 3-session model
4 Quick treatment "fast hemorrhoid treatment," "hemorrhoid fix without time off" High 10-minute, same-day return to work messaging
5 Grade III anxiety "grade 3 hemorrhoids treatment options" High Target Grade III explicitly in content + ad copy
6 Symptom searches "hemorrhoid won't go away," "bleeding hemorrhoid" Very High Top-of-funnel symptom content, entry point SEO
7 Local search "hemorrhoid doctor near me Seattle," "hemorrhoid specialist Seattle" High GBP + local SEO — critical for Seattle geo
8 Cost / insurance "hemorrhoid treatment cost without insurance," "hemorrhoid banding cost" Medium-High Address cash-pay directly; offer financing options
9 New procedure "new hemorrhoid treatment 2025 2026," "latest hemorrhoid procedure" Medium FAST as the "what's new" — recency is credibility
10 Physician comparison "best hemorrhoid specialist Seattle," "hemorrhoid surgeon rating" Medium Physician bio page + credentials + Healthgrades
Top 10 Patient Search Intent Themes
1
ThemeSurgery fear
Patient Language"hemorrhoid surgery recovery," "hemorrhoidectomy pain stories"
Signal StrengthVery High
Marketing ApplicationLead with pain-free messaging; contrast with surgery
2
ThemeOTC failure
Patient Language"preparation H stopped working," "hemorrhoid cream not working"
Signal StrengthVery High
Marketing Application"When ointments stop working" hook
3
ThemeBanding comparison
Patient Language"hemorrhoid banding vs surgery," "rubber band ligation alternatives"
Signal StrengthHigh
Marketing ApplicationSingle-session positioning vs. CRH 3-session model
4
ThemeQuick treatment
Patient Language"fast hemorrhoid treatment," "hemorrhoid fix without time off"
Signal StrengthHigh
Marketing Application10-minute, same-day return to work messaging
5
ThemeGrade III anxiety
Patient Language"grade 3 hemorrhoids treatment options"
Signal StrengthHigh
Marketing ApplicationTarget Grade III explicitly in content + ad copy
6
ThemeSymptom searches
Patient Language"hemorrhoid won't go away," "bleeding hemorrhoid"
Signal StrengthVery High
Marketing ApplicationTop-of-funnel symptom content, entry point SEO
7
ThemeLocal search
Patient Language"hemorrhoid doctor near me Seattle," "hemorrhoid specialist Seattle"
Signal StrengthHigh
Marketing ApplicationGBP + local SEO — critical for Seattle geo
8
ThemeCost / insurance
Patient Language"hemorrhoid treatment cost without insurance," "hemorrhoid banding cost"
Signal StrengthMedium-High
Marketing ApplicationAddress cash-pay directly; offer financing options
9
ThemeNew procedure
Patient Language"new hemorrhoid treatment 2025 2026," "latest hemorrhoid procedure"
Signal StrengthMedium
Marketing ApplicationFAST as the "what's new" — recency is credibility
10
ThemePhysician comparison
Patient Language"best hemorrhoid specialist Seattle," "hemorrhoid surgeon rating"
Signal StrengthMedium
Marketing ApplicationPhysician bio page + credentials + Healthgrades
14

Unmet Needs Map

Unmet Need What Patients Are Saying FAST Answer
Single-session treatment "I don't have time for 3 appointments" One 10-minute visit — no return sessions required
Pain-free recovery "Anything that doesn't hurt like surgery" 92% of patients in published study reported zero pain
Fast return to normal "I can't take 2 weeks off work" Same-day or next-day return to work for most patients
Published evidence for a new procedure "How do I know this actually works?" Sias & Milone (2025), open-access, peer-reviewed, 5-year outcomes
Local availability "Is there anywhere near me that does this?" Seattle launch (GBP, local SEO, and geo-targeted ads are critical)
Financing for cash-pay "I don't have $4K sitting around" CareCredit / patient financing from clinic launch
Physician credibility "Who are the doctors and what are their credentials?" Named physicians (Dr. Sias, Dr. Milone), institutional affiliations
Unmet Needs Map
Single-session treatment
What Patients Are Saying"I don't have time for 3 appointments"
FAST AnswerOne 10-minute visit — no return sessions required
Pain-free recovery
What Patients Are Saying"Anything that doesn't hurt like surgery"
FAST Answer92% of patients in published study reported zero pain
Fast return to normal
What Patients Are Saying"I can't take 2 weeks off work"
FAST AnswerSame-day or next-day return to work for most patients
Published evidence for a new procedure
What Patients Are Saying"How do I know this actually works?"
FAST AnswerSias & Milone (2025), open-access, peer-reviewed, 5-year outcomes
Local availability
What Patients Are Saying"Is there anywhere near me that does this?"
FAST AnswerSeattle launch (GBP, local SEO, and geo-targeted ads are critical)
Financing for cash-pay
What Patients Are Saying"I don't have $4K sitting around"
FAST AnswerCareCredit / patient financing from clinic launch
Physician credibility
What Patients Are Saying"Who are the doctors and what are their credentials?"
FAST AnswerNamed physicians (Dr. Sias, Dr. Milone), institutional affiliations

WHAT CHANGED

The Brand Is FAST, Not "Meribel Health"

The Figma website design establishes a consumer-facing procedure brand called "FAST." This is the right strategic call — patients search for procedures (LASIK, Invisalign, Botox), not for holding companies. Meribel Health is the corporate credibility layer; FAST is the patient-facing identity. The website nav confirms this: "The Procedure | About Us | Contact Us" — built around the procedure, not the company.

So What: All patient-facing marketing — ads, website, GBP, social, email, review platforms — should lead with FAST. Meribel Health branding belongs in press releases, investor materials, physician-to-physician communications, and regulatory submissions. Brand confusion between FAST and Meribel Health will fragment search authority and reduce recall.

WHAT CHANGED

TSH Competes With Patient Inaction, Not With Surgeons

The primary competitive barrier is not CRH O'Regan or hemorrhoidectomy — it is the estimated 6.9 million Americans with Grade II–III hemorrhoids who are doing nothing. Most patients in this category have tried OTC products, watched them fail, and concluded that no good option exists between "keep buying Preparation H" and "undergo a surgery that everyone says is miserable." They are not choosing between procedures. They have exited the decision entirely.

So What: Messaging should not lead with procedure comparison. It should lead with re-engagement: "there's a better option that most doctors haven't told you about yet." The first job of every campaign is to interrupt the assumption that nothing between ointments and surgery exists.

WHAT CHANGED

Regulatory Status Includes FDA, CE, and EU-MDR Trust Badges

The Figma website design displays FDA, CE, and EU-MDR regulatory trust badges — indicating coverage across US and EU markets. If accurate, these represent a significant credibility signal that few procedure-brand competitors can display. Trust badges reduce patient skepticism and convert high-intent visitors.

So What: Confirm the exact regulatory clearance status with Gareth and legal counsel before the site goes live. Displaying regulatory badges that overstate or misrepresent the device's status is an FDA enforcement trigger and FTC liability. Verify first — then make this a prominent website and ad creative element.

WHAT CHANGED

The Explainer Video Is a Liability, Not an Asset

An existing video contains claims that are no longer legally permissible under FDA medical device advertising regulations. The risk is not just the video itself — it is the probability that claims from the video have already been repeated in other materials, conversations, or slide decks.

So What: Archive the video with a "DO NOT DISTRIBUTE" label immediately. Every new creative asset must be independently substantiated against the published study and reviewed against guardrails.md before production. No claims from any Meribel asset should be taken at face value without tracing back to the Sias & Milone (2025) publication or verified regulatory filings.

WHAT CHANGED

The Journal Article Contains a Data Discrepancy That Must Be Resolved

The published study (Sias & Milone 2025) states "220 male and 128 female" as the patient gender breakdown — which sums to 348, not 248 (the stated study sample size). The introduction cites 232 patients; the methods section cites 248. The source of the discrepancy (whether it reflects a revision, a subset analysis, or an error) has not been clarified publicly.

So What: Only cite "248 patients" as the study sample size in all marketing materials, as that is the methods-section figure. Do not cite the 63%/37% gender split (220 male / 128 female) until clarified with the authors, as those numbers do not reconcile with 248. Do not let this discrepancy appear in patient-facing materials — it undermines the credibility of the entire evidence foundation. Gareth should seek clarification from Dr. Sias or the journal directly.

WHAT CHANGED

The Physician Referral Channel Has Near-Zero Competition in the Current Window

CRH O'Regan's model trains GI physicians as distributors — creating a physician loyalty relationship that is hard to displace once established. FAST's patient-direct model is not competing for physician loyalty. But the referral channel — GI physicians who encounter a patient asking specifically for a minimally invasive option — remains available and is currently underserved. The THD "investigational" reclassification removed the most common referral destination for this patient type.

So What: Gareth should personally meet the top 20 GI and colorectal surgery practices within 30 miles of the Seattle clinic before it opens. A physician referral relationship established before launch produces first-week revenue. The window where these physicians have no alternative referral destination will not remain open indefinitely.

WHAT CHANGED

Seattle Launch Must Target the September–November 2026 Demand Peak

Hemorrhoid treatment demand follows two predictable annual peaks: January–March (deductible resets, New Year health motivation) and September–November (year-end insurance urgency, fall behavior patterns). If the Seattle clinic opens in summer 2026, the first meaningful revenue window is September–November. Missing that window means waiting until January 2027.

So What: Reverse-engineer all infrastructure timelines from September 2026. Website needs to be live by June. Google Ads by July. GBP by May. SEO content needs to be indexed before September — which means writing and publishing from April onward. The clock is already running.

WHAT CHANGED

Cash-Pay Is the Launch Model — And the Comparables Prove It

At $3,000–$5,000 per procedure, FAST is priced comparably to LASIK eye surgery ($2,000–$4,000 per eye) and significantly below hemorrhoidectomy ($5,000–$12,000 fully loaded). LASIK has operated primarily as a cash-pay procedure for decades. Sono Bello is cash-pay across 80+ locations. Invisalign is out-of-pocket for most patients. These brands collectively serve millions of procedures annually without insurance coverage.

So What: Cash-pay is not a gap in the business model — it is the business model at launch. Patients who have suffered for 2–5 years and have finally found a credible one-session, same-day option are not price-shopping between FAST and surgery. They are comparing FAST to continued suffering. The target patient is a motivated buyer. The pricing conversation is about financing options, not about lowering the price.

---

Act III

ICPs & Positioning

15

ICP Priority Matrix

Persona % of Reachable TAM Primary Channel Entry Hook Time to Decision Retention / Referral
Marcus — The Avoider ~45% Paid search, SEO Fear of surgery messaging 2–4 weeks High — word-of-mouth to peer group
Sarah — The Researcher ~30% SEO, physician referral Evidence-based differentiation 3–6 weeks Very High — NPS drivers, written reviews
Robert — The Repeat Patient ~25% Physician referral, branded search Single-session durability 1–2 weeks Medium — repeat treatment if needed
ICP Priority Matrix
~45%
~30%
~25%
Marcus — The Avoider~45%
Sarah — The Researcher~30%
Robert — The Repeat Patient~25%

Marcus — "The Reluctant Avoider"

Age 42–55 | Male | Professional | Grade III | 2–5 years of OTC management

Core Attributes
Attribute Detail
Age Range 42–55
Condition Grade III internal hemorrhoids
Treatment History OTC only — Preparation H, fiber supplements, sitz baths
Primary Fear Surgery pain and 2–4 week recovery time
Decision Style Avoidance until pain or interference with daily function forces action
Insurance Employer-sponsored — but will pay out-of-pocket to avoid surgery
Income $80K–$150K household income
Core Attributes
Age Range42–55
ConditionGrade III internal hemorrhoids
Treatment HistoryOTC only — Preparation H, fiber supplements, sitz baths
Primary FearSurgery pain and 2–4 week recovery time
Decision StyleAvoidance until pain or interference with daily function forces action
InsuranceEmployer-sponsored — but will pay out-of-pocket to avoid surgery
Income$80K–$150K household income
Snapshot

Marcus has been managing his hemorrhoids for two or more years with over-the-counter products. He knows they're getting worse. He has already looked up hemorrhoidectomy and ruled it out immediately — the recovery stories on forums and Reddit confirmed what he suspected: weeks of severe pain, time off work he can't afford, and a procedure that everyone around him seemed to dread. He doesn't know TSH or FAST exists. He searches sporadically, almost always in private browsing mode, on his phone, late at night: "hemorrhoid treatment without surgery," "hemorrhoid alternatives," "is there a quick hemorrhoid fix." He is not looking for more information about his condition. He is looking for permission to act.

Daily Reality
  • Works in a demanding professional role with limited flexibility for 2–4 weeks of surgical recovery
  • Has not told his partner, friends, or employer the full extent of his symptoms
  • Searches hemorrhoid content only on his phone, in private browsing mode
  • Has tried at least 2–3 OTC products with diminishing returns over time
  • Pain is now affecting exercise performance, travel comfort, and concentration at work
  • Has a high embarrassment threshold — would prefer to handle this without involving anyone he knows
Core Fears

Surgery pain and recovery time | Permanent complications (incontinence, stenosis) | Embarrassment at a consultation | "What if it comes back after treatment"

What Converts Marcus

A single search ad with "back to work the same day" in the headline. A landing page with a specific data point (92% pain-free, 248 patients in a published study) and a named physician. A consultation booking process that is private, fast to schedule, and non-judgmental in tone.

Marcus Treatment Cycle
Phase Marcus's State Reachability Key Message
OTC stage Denial — "it'll get better" Low Not meaningfully reachable
OTC failure Awareness — "I need to look into this" Medium SEO: "When hemorrhoid creams stop working"
Active research High intent — "what are my options?" HIGH Paid search: "10-minute procedure, same-day return to work"
Consultation booked Decision — committed HIGHEST Nurture email: clinical evidence + physician bio
Post-procedure Advocacy — surprised and relieved HIGH Review request + referral ask (30-day post-procedure)
Marcus Treatment Cycle
OTC stage
Marcus's StateDenial — "it'll get better"
ReachabilityLow
Key MessageNot meaningfully reachable
OTC failure
Marcus's StateAwareness — "I need to look into this"
ReachabilityMedium
Key MessageSEO: "When hemorrhoid creams stop working"
Active research
Marcus's StateHigh intent — "what are my options?"
ReachabilityHIGH
Key MessagePaid search: "10-minute procedure, same-day return to work"
Consultation booked
Marcus's StateDecision — committed
ReachabilityHIGHEST
Key MessageNurture email: clinical evidence + physician bio
Post-procedure
Marcus's StateAdvocacy — surprised and relieved
ReachabilityHIGH
Key MessageReview request + referral ask (30-day post-procedure)
Trust Hierarchy (Most to Least Influential)
Step 1
Specific outcome data (92% pain-free, 248 patients, named study)
Step 2
Named physician with credentials and institutional affiliation
Step 3
Published journal article (open-access, peer-reviewed)
Step 4
Google reviews (volume and recency matter equally)
Step 5
Website clarity and professional clinical design
Step 6
Insurance and payment options transparency
Step 7
Friend or colleague who has undergone the procedure

Sarah — "The Informed Advocate"

Age 35–50 | Female | Health-conscious professional | Grade II–III | Recently symptomatic or post-pregnancy exacerbation

Core Attributes
Attribute Detail
Age Range 35–50
Condition Grade II–III internal hemorrhoids
Treatment History First-time treatment-seeker, or post-pregnancy exacerbation of prior symptoms
Primary Motivation Find the safest, most evidence-backed option available
Decision Style Research-then-act — will not book until fully satisfied with evidence
Research Depth Deep — reads the actual study, looks up physician credentials
Income $90K–$175K household income
Core Attributes
Age Range35–50
ConditionGrade II–III internal hemorrhoids
Treatment HistoryFirst-time treatment-seeker, or post-pregnancy exacerbation of prior symptoms
Primary MotivationFind the safest, most evidence-backed option available
Decision StyleResearch-then-act — will not book until fully satisfied with evidence
Research DepthDeep — reads the actual study, looks up physician credentials
Income$90K–$175K household income
Snapshot

Sarah approaches medical decisions the way she approaches any major purchase — with thorough research. She will read the published study. She will look up Dr. Sias and Dr. Milone on PubMed. She will check the credibility of Gavin Publishers. She will read every Google review and every Healthgrades review. She will look for red flags more actively than she looks for green lights. When she finds FAST, she is likely to be more excited than skeptical — because she has been looking for exactly this kind of option and knows what good clinical evidence looks like. Her conversion barrier is not fear of pain. It is trust: is this clinic legitimate, is the evidence real, and is this the right choice for her specific situation?

Core Fears

Making the wrong medical choice | Inadequate evidence base for a new procedure | Dismissive or overselling physicians | Long-term outcomes not matching the published data | "Is this clinic legitimate or is it a mill?"

What Converts Sarah

The full published study linked directly from the website. Detailed physician bios with credentials, training background, and institutional affiliations. A thorough, honest FAQ page that addresses complications, not just successes. Specific complication rates presented transparently (including the minor bleeding at 15.3%). A clean, clinical environment at the consultation. The mention of controlled trials in Paris and NYC as evidence of ongoing scientific rigor.

Trust Hierarchy (Most to Least Influential)
Step 1
Peer-reviewed journal article (open-access, with full text available)
Step 2
Physician credentials, specialty board certification, and institutional affiliations
Step 3
Specific complication data — including the honest numbers, not just the favorable ones
Step 4
Information about the planned Paris/NYC controlled trials (demonstrates scientific commitment)
Step 5
Google and Healthgrades review volume and rating
Step 6
Website clinical tone, content quality, and absence of hyperbole
Step 7
Peer recommendations from other health-literate patients

Robert — "The Repeat Sufferer"

Age 50–65 | Male | Had prior treatment (banding or prior surgery) | Grade III recurring | Physician-referred or branded search

Core Attributes
Attribute Detail
Age Range 50–65
Prior Treatment Prior rubber band ligation (CRH O'Regan), prior hemorrhoidectomy, or both
Current State Recurring Grade III symptoms — the prior treatment did not hold
Primary Need One definitive solution with real, published 5-year durability data
Patience Level Low — has already been through the treatment cycle and is done waiting
Decision Speed Fast when physician-referred — 1–2 weeks from referral to consultation
Core Attributes
Age Range50–65
Prior TreatmentPrior rubber band ligation (CRH O'Regan), prior hemorrhoidectomy, or both
Current StateRecurring Grade III symptoms — the prior treatment did not hold
Primary NeedOne definitive solution with real, published 5-year durability data
Patience LevelLow — has already been through the treatment cycle and is done waiting
Decision SpeedFast when physician-referred — 1–2 weeks from referral to consultation
Snapshot

Robert is done being patient. He has had banding sessions that didn't last — he went through 3 sessions over 6 weeks, felt relief for a year, then watched the symptoms return. Or he had a hemorrhoidectomy years ago and has new prolapse with recurrence. He has healthcare literacy from experience — he asks harder, more specific questions than Marcus or Sarah. When his GI physician mentions a new option, he goes home and reads everything that night before calling in the morning. He is the most valuable lead source in the funnel: high clinical candidacy, high conversion rate from consultation to procedure, physician-referred so acquisition cost is near zero, and he becomes a vocal advocate if the outcome matches his expectations.

Core Fears

Yet another treatment that doesn't last | Procedure downtime he has already experienced before and can't afford again | Spending $4,000 on something that fails | Physicians who oversell and underdeliver | "Is the 5-year data actually credible?"

What Converts Robert

Honest recurrence data cited from the published study: 87% asymptomatic at 5 years, 12.9% requiring a localized retreatment procedure. A physician who is direct and specific about what the procedure does and does not guarantee. The fact that retreatment — if needed — is a simple localized procedure, not a full surgery. Institutional credibility: Brooklyn Hospital Center, a named surgeon (Dr. Milone), the published paper.


16

Core Positioning Statement

"For adults with Grade II–III internal hemorrhoids who have failed conservative treatment and fear surgical hemorrhoidectomy, FAST is the 10-minute minimally invasive procedure with near-zero pain and same-day recovery, backed by published 5-year outcomes for 248 patients."

17

Brand Architecture

Layer Name Audience Role
Procedure brand FAST Patients Patient-facing identity, search destination, emotional hook
Corporate entity Meribel Health Physicians, investors, press, regulators Credibility layer, IP holder, clinical evidence owner
Device IP Proprietary anoscope Physicians, regulators Competitive moat, clinical precision claim
Brand Architecture
Procedure brand
NameFAST
AudiencePatients
RolePatient-facing identity, search destination, emotional hook
Corporate entity
NameMeribel Health
AudiencePhysicians, investors, press, regulators
RoleCredibility layer, IP holder, clinical evidence owner
Device IP
NameProprietary anoscope
AudiencePhysicians, regulators
RoleCompetitive moat, clinical precision claim
18

Evidence Hierarchy by Phase

Phase Evidence Level Language Permitted Marketing Scope
Pre-launch (now — April 2026) Level IV — case series, 248 patients "In a published case series of 248 patients..." Seattle geo, cash-pay, patient-direct
Post-trial publication (est. 2027) Level I/II — randomized controlled trial "In a controlled clinical trial..." Multi-city, insurance submission package
Mature evidence phase (2028+) Multiple studies + patient registry "Established outcomes data for Grade II–III..." National, insurance-covered, standard of care pursuit
Evidence Hierarchy by Phase
Pre-launch (now — April 2026)
Evidence LevelLevel IV — case series, 248 patients
Language Permitted"In a published case series of 248 patients..."
Marketing ScopeSeattle geo, cash-pay, patient-direct
Post-trial publication (est. 2027)
Evidence LevelLevel I/II — randomized controlled trial
Language Permitted"In a controlled clinical trial..."
Marketing ScopeMulti-city, insurance submission package
Mature evidence phase (2028+)
Evidence LevelMultiple studies + patient registry
Language Permitted"Established outcomes data for Grade II–III..."
Marketing ScopeNational, insurance-covered, standard of care pursuit
19

Differentiator Hierarchy

Rank Differentiator Defensibility Patient Impact Evidence Source
1 10-min procedure, same-day recovery High — mechanism-based Highest — overcomes #1 barrier Published (Sias & Milone 2025)
2 92% zero pain in first 5 post-op days High — published data Highest — vs. surgery fear Published (Sias & Milone 2025)
3 Zero stenosis / zero incontinence / zero infection High — published High — addresses surgical complication fear Published (Sias & Milone 2025)
4 87% asymptomatic at 5-year follow-up Medium — single-center High — durability questions are universal Published (Sias & Milone 2025)
5 Anatomical restoration vs. tissue removal High — mechanism Medium — resonates with informed patients Published mechanism description
6 Patented device — proprietary anoscope High — IP protection Low — not patient-facing language Patent filings
7 Owned-clinic experience model High — operational moat Medium — vs. physician network model Strategic positioning
Differentiator Hierarchy
1
Differentiator10-min procedure, same-day recovery
DefensibilityHigh — mechanism-based
Patient ImpactHighest — overcomes #1 barrier
Evidence SourcePublished (Sias & Milone 2025)
2
Differentiator92% zero pain in first 5 post-op days
DefensibilityHigh — published data
Patient ImpactHighest — vs. surgery fear
Evidence SourcePublished (Sias & Milone 2025)
3
DifferentiatorZero stenosis / zero incontinence / zero infection
DefensibilityHigh — published
Patient ImpactHigh — addresses surgical complication fear
Evidence SourcePublished (Sias & Milone 2025)
4
Differentiator87% asymptomatic at 5-year follow-up
DefensibilityMedium — single-center
Patient ImpactHigh — durability questions are universal
Evidence SourcePublished (Sias & Milone 2025)
5
DifferentiatorAnatomical restoration vs. tissue removal
DefensibilityHigh — mechanism
Patient ImpactMedium — resonates with informed patients
Evidence SourcePublished mechanism description
6
DifferentiatorPatented device — proprietary anoscope
DefensibilityHigh — IP protection
Patient ImpactLow — not patient-facing language
Evidence SourcePatent filings
7
DifferentiatorOwned-clinic experience model
DefensibilityHigh — operational moat
Patient ImpactMedium — vs. physician network model
Evidence SourceStrategic positioning

20

By Persona

Persona Primary Hook Proof Point CTA Tone
Marcus "Back to work the same day. No surgery." 92% pain-free, 10 minutes, 248 patients "See if you're a candidate" Direct, empathetic, private
Sarah "Published 5-year outcomes. Real data." 248 patients, Sias & Milone 2025, open-access "Read the research" Clinical, thorough, evidence-respectful
Robert "One session. Lasting results." 87% asymptomatic at 5 years; retreatment available if needed "Talk to a physician" Direct, honest, no overselling
By Persona
Marcus
Primary Hook"Back to work the same day. No surgery."
Proof Point92% pain-free, 10 minutes, 248 patients
CTA"See if you're a candidate"
ToneDirect, empathetic, private
Sarah
Primary Hook"Published 5-year outcomes. Real data."
Proof Point248 patients, Sias & Milone 2025, open-access
CTA"Read the research"
ToneClinical, thorough, evidence-respectful
Robert
Primary Hook"One session. Lasting results."
Proof Point87% asymptomatic at 5 years; retreatment available if needed
CTA"Talk to a physician"
ToneDirect, honest, no overselling
21

By Channel

Channel Audience Message Emphasis Format Guardrail
Google Search (symptom-intent) Marcus, Robert "Alternative to surgery" + speed Headline + single CTA No "painless" as absolute claim
Google Search (comparison) Sarah Clinical evidence + outcome durability Sitelinks + study citation Cite Sias & Milone 2025
Google Business Profile All (local) Location + booking + patient reviews Profile optimization + weekly posts No unverified outcome claims
Physician referral packet GI / PCP / colorectal surgeons Clinical credibility + CPT pathway + referral form PDF leave-behind + online form Full study limitations disclosed
Email nurture (post-inquiry) All Education + fear reduction + evidence 3-email drip sequence No diagnosis advice; include "individual results may vary"
Meta awareness Sarah, Marcus (upper funnel) "There's a better option" + procedure education Short-form video + static creative FTC disclosure; no health condition targeting
By Channel
Google Search (symptom-intent)
AudienceMarcus, Robert
Message Emphasis"Alternative to surgery" + speed
FormatHeadline + single CTA
GuardrailNo "painless" as absolute claim
Google Search (comparison)
AudienceSarah
Message EmphasisClinical evidence + outcome durability
FormatSitelinks + study citation
GuardrailCite Sias & Milone 2025
Google Business Profile
AudienceAll (local)
Message EmphasisLocation + booking + patient reviews
FormatProfile optimization + weekly posts
GuardrailNo unverified outcome claims
Physician referral packet
AudienceGI / PCP / colorectal surgeons
Message EmphasisClinical credibility + CPT pathway + referral form
FormatPDF leave-behind + online form
GuardrailFull study limitations disclosed
Email nurture (post-inquiry)
AudienceAll
Message EmphasisEducation + fear reduction + evidence
Format3-email drip sequence
GuardrailNo diagnosis advice; include "individual results may vary"
Meta awareness
AudienceSarah, Marcus (upper funnel)
Message Emphasis"There's a better option" + procedure education
FormatShort-form video + static creative
GuardrailFTC disclosure; no health condition targeting

Act IV

Acquisition

22

Google Ads + SEO Funnel (Month 6 Target — Seattle Geo)

Stage Monthly Volume Conversion Rate Notes
Impressions (Seattle paid search) 60,000–80,000 Symptom-intent + comparison keyword set
Clicks 900–1,200 1.5% CTR Medical procedure average — conservative
Leads (form + call combined) 117–156 13% CVR Target landing page conversion rate
Booked Consultations 70–109 60–70% Same-day callback drives booking rate
Clinical Candidates 56–87 80% candidacy TSH-eligible: Grade II–III confirmed
Procedures Scheduled 25–48 45% decision Cash-pay friction is primary variable
Procedures Completed 24–46 95% show rate Confirmation sequence + day-before reminder
Monthly Revenue $96K–$184K At $4,000 per procedure
Google Ads + SEO Funnel (Month 6 Target — Seattle Geo)
Impressions (Seattle paid search)
Monthly Volume60,000–80,000
Conversion Rate
NotesSymptom-intent + comparison keyword set
Clicks
Monthly Volume900–1,200
Conversion Rate1.5% CTR
NotesMedical procedure average — conservative
Leads (form + call combined)
Monthly Volume117–156
Conversion Rate13% CVR
NotesTarget landing page conversion rate
Booked Consultations
Monthly Volume70–109
Conversion Rate60–70%
NotesSame-day callback drives booking rate
Clinical Candidates
Monthly Volume56–87
Conversion Rate80% candidacy
NotesTSH-eligible: Grade II–III confirmed
Procedures Scheduled
Monthly Volume25–48
Conversion Rate45% decision
NotesCash-pay friction is primary variable
Procedures Completed
Monthly Volume24–46
Conversion Rate95% show rate
NotesConfirmation sequence + day-before reminder
Monthly Revenue
Monthly Volume$96K–$184K
Conversion Rate
NotesAt $4,000 per procedure
23

Physician Referral Funnel (Month 6 Target)

Stage Volume Rate Notes
Active referring physicians 5–7 Target: 10 active by Month 12
Referrals per physician per month 2–4 Standard GI referral volume for this condition
Monthly referral leads 10–28 Pre-qualified, high intent, physician-primed
Consultations completed 9–25 90%+ Physician-referred patients show at very high rates
Procedures completed 7–19 75% Higher conversion than paid search — already motivated
PAC (physician channel) ~$75 Relationship cost amortized over monthly referral volume
Physician Referral Funnel (Month 6 Target)
Active referring physicians
Volume5–7
Rate
NotesTarget: 10 active by Month 12
Referrals per physician per month
Volume2–4
Rate
NotesStandard GI referral volume for this condition
Monthly referral leads
Volume10–28
Rate
NotesPre-qualified, high intent, physician-primed
Consultations completed
Volume9–25
Rate90%+
NotesPhysician-referred patients show at very high rates
Procedures completed
Volume7–19
Rate75%
NotesHigher conversion than paid search — already motivated
PAC (physician channel)
Volume~$75
Rate
NotesRelationship cost amortized over monthly referral volume
24

Unit Economics Scenarios

Scenario CPL Consult Rate Proc Rate PAC LTV:PAC
Conservative (launch) $150 40% 45% $833 4.8:1
Base (Month 6) $120 50% 50% $480 8.3:1
Optimized (Month 12) $100 55% 55% $331 12.1:1
Physician referral ~$50 85% 75% ~$78 51:1
Unit Economics Scenarios
Conservative (launch)
40%
Base (Month 6)
50%
Optimized (Month 12)
55%
Physician referral
85%

25

Tier 1 — Build Before Day 1

Google Search — Seattle Geo

Patient-direct paid search is the fastest path to high-intent leads for a new procedure clinic. Symptom-intent queries ("hemorrhoid treatment near me Seattle," "hemorrhoid banding alternative," "minimally invasive hemorrhoid procedure") carry very high commercial intent from patients who are already in the research or decision stage. LASIK and Sono Bello benchmarks suggest $82–$150 CPL is achievable at campaign maturity, with medical procedures typically seeing 10–15% landing page conversion rates on well-optimized pages.

  • Budget: $5K–$10K/month at launch; scale to $15K+ as CPL data matures
  • Campaign structure: Treatment-intent | Symptom-based | Comparison queries | Branded
  • Target CPL: $120–$150 at launch; $100 by Month 6
  • Key requirement: HIPAA-compliant landing page, call tracking (CallRail), GA4 conversion events configured before the first dollar is spent
  • Google Ads certification required for healthcare advertising category — verify with Amanda before launch
Google Business Profile

For "hemorrhoid treatment near me" and "hemorrhoid doctor Seattle" queries, the GBP local pack appears above paid results. Zero cost. First-mover advantage in the Seattle market compounds with review velocity — a GBP with 20 reviews at 4.8 stars will outperform any paid result for local-intent searchers.

  • Complete profile: address, hours, photos, services description, booking link
  • Appointment booking link connected directly to the consultation request form
  • Post cadence: 1–2 posts per week (educational content, procedure information, outcome highlights with citations)
  • Review capture: automated Day 7 and Day 30 post-procedure text/email with Google review link
  • GBP must be verified and live before the clinic opens — not on opening day, before
Physician Referral Program

Highest-quality leads at the lowest acquisition cost in the funnel. Physician-referred patients convert at 75%+ from consultation to procedure and arrive pre-educated about the procedure from the referring physician. GI physicians in Seattle who previously referred Grade II–III patients to THD providers now have a vacancy in their referral algorithm. Gareth's physician-to-physician credibility is an asset that cannot be replicated by Amanda or a marketing agency.

  • Target: Top 50 GI, internal medicine, and colorectal surgery practices within 30 miles of the Seattle clinic
  • Referral packet contents: clinical summary of TSH, full Sias & Milone (2025) paper, patient selection criteria (Grade II–III, failed conservative management), referral form, clinic contact information
  • CRM-based referral attribution: track every referred patient back to the referring physician
  • Quarterly outcomes report to referring physicians using anonymized aggregate data — builds trust and keeps the relationship active
  • Gareth to begin personal outreach immediately; 20 in-person visits before clinic opening is the target
26

Tier 2 — Start Early, Compound Over Time

SEO and Content Marketing

Organic search is the highest long-term ROI channel for medical procedures but requires 4–8 months of consistent content production and technical SEO before meaningful traffic arrives. Starting content production in April 2026 means content may begin ranking by September 2026 — the first demand peak. Starting in July means missing that window entirely.

Priority keyword clusters:

hemorrhoid treatment Seattle" / "hemorrhoid doctor Seattle
minimally invasive hemorrhoid surgery alternatives
hemorrhoid banding vs surgery comparison
grade 3 hemorrhoid treatment options
hemorrhoid treatment without surgery
how long is hemorrhoid recovery

Content plan:

  • 5 foundational pages at launch: procedure page, comparison page, FAQ page, Seattle location page, "when OTC fails" patient education page
  • 2 long-form blog posts per month on symptom content and treatment comparison
  • All content physician-reviewed for E-E-A-T compliance (Experience, Expertise, Authoritativeness, Trustworthiness — critical for medical content Google ranking)
  • Schema markup on all relevant pages: MedicalProcedure, MedicalClinic, Physician, FAQPage
Meta Ads — Awareness (Month 3+)

Medical procedure advertising on Meta faces platform-level restrictions (no before/after imagery in ad creative, no targeting by health condition or medical interest). However, awareness-level campaigns targeting Seattle-metro adults 35–65 with health, wellness, and general interest signals can seed brand recognition that materially improves paid search performance and reduces CPL through improved brand recall.

  • Creative approach: educational ("did you know?"), outcome-framed ("back to work same day — how?"), physician credibility video
  • Audience targeting: Seattle DMA, ages 35–65, general health + wellness interest signals; lookalike from consultation form visitors once pixel data exists
  • Budget: $2K–$5K/month starting Month 3; scale based on CPC and lead quality data
  • Compliance: No health condition targeting; no before/after in ad creative; FTC disclosure on any endorsed or testimonial content
27

Tier 3 — Post-Launch Optimization

Retargeting (Month 2+)

Medical procedure consideration cycles are long — LASIK benchmarks show 62% of patients research for more than one month before booking. Website visitors who don't convert on first visit can be retargeted on Google Display and Meta over a 30–90 day window with educational content, clinical evidence cards, and (when consented patients are available) outcome stories.

  • Pixel must be live from website Day 1 — no retargeting audience builds without pixel data
  • Creative rotation: clinical evidence cards → FAQ answers → consultation CTA progression
  • Audience exclusions: existing patients (exclude by email match), consultations already booked
  • HIPAA consideration: retargeting pixels on medical content pages require privacy policy disclosure and HIPAA BAA with ad platforms where applicable
Influencer and KOL Program (Month 4+)

Amanda's influencer list represents a channel with high awareness reach potential but significant compliance overhead. FTC disclosure requirements are non-negotiable for all paid influencer relationships. Medical professional KOLs (gastroenterologists, colorectal surgeons with social media presence) carry the highest credibility for physician-referral channel activation. Patient advocates have high reach for Marcus and Sarah persona awareness.

  • Priority tier: Medical professional KOLs — physician-to-physician credibility for GI referral channel
  • Secondary tier: Health and wellness content creators — patient awareness for Marcus/Sarah personas
  • Compliance requirements: Every post must include explicit paid relationship disclosure AND must comply with all guardrails in guardrails.md for clinical claims. Meribel is legally responsible for monitoring and correcting influencer content that violates FDA or FTC standards.
  • Content approval: Every influencer post must be reviewed and approved against guardrails.md before publishing

Act V

Creative

Symptom and OTC Failure Hooks — Marcus and Robert:

WHAT CHANGED

When Ointments Stop Working, Most Patients Give Up

"Hemorrhoid creams stop working for Grade II–III disease. Most patients don't know that better options exist. They're not choosing between treatments — they've concluded nothing works. They've decided to live with it. The hook that intercepts this patient is not 'try FAST instead of surgery.' It's 'there's something you probably haven't heard about yet.'"

So What: The highest-converting hook intercepts the patient who has already failed OTC and is looking for anything credible. The message is: "There's a procedure most doctors haven't mentioned yet — and it's backed by a published 5-year study."

WHAT CHANGED

"The Surgery I Was Afraid Of" Is the Wrong Comparison

"Most patients comparing treatment options are not actually choosing between FAST and hemorrhoidectomy. They're choosing between FAST and continued suffering. The frame 'we're better than surgery' misses the real competitive dynamic — the patient has already eliminated surgery from consideration. The real alternative being offered is 'keep doing what you're doing for the next 5 years.'"

So What: Reframe the competitive set in every ad and landing page. The alternative to FAST is not surgery — it is continued suffering. Every messaging choice should make that contrast explicit.

---

Hook: "I was out of work for 3 weeks after hemorrhoid surgery. I wish I'd known there was another way."

Patient story hook in post-procedure testimonial format. Available once consented patients exist. Targets the Marcus persona (surgery fear is the primary conversion driver). Effective as a video testimonial, a quote card in Meta ads, or an email subject line. Requires HIPAA authorization and media release from patient. Must include "Individual results may vary" disclosure.

Hook: "10 minutes. The doctor used a specialized device. I went back to work the next day."

Outcome hook targeting the specific disbelief that a 10-minute outpatient procedure can resolve Grade III hemorrhoids permanently. Targets all three personas — the specificity ("10 minutes," "the next day") is the credibility signal. Works as a Google Ads headline combination, landing page hero statement, or organic social caption. Substantiated by Sias & Milone (2025).

Hook: "92% of patients reported zero pain in the 5 days after the procedure."

Evidence hook — verbatim data from the published study, properly framed as a study-population statistic (not an absolute guarantee). Targets Sarah (research-driven persona). Works as a Google Ads headline, landing page hero stat, email content block, or physician referral packet callout. Always pair with citation: "Sias & Milone 2025, Journal of Surgery, 248 patients."

Hook: "Hemorrhoid banding requires 3 appointments over 6 weeks. This takes 10 minutes, once."

Comparison hook targeting the multi-session fatigue barrier most commonly associated with CRH O'Regan patients and their referring physicians. Targets Robert (the repeat sufferer who has been through banding cycles). Also effective for GI physician outreach where the conversation starts with "why is this better than what I already refer to?"

Hook: "87% of patients were completely asymptomatic at their 5-year follow-up."

Durability hook — targets the universal concern across all personas: "will this last?" The 5-year outcome data is FAST's most defensible long-term differentiator, as most competing procedure brands do not have equivalent published follow-up data. Works on landing pages, in physician referral packets, and in email nurture sequences for patients in extended consideration cycles.

Hook: "We respond to inquiries in English, French, or Italian. Your privacy matters."

Trust and privacy hook drawn from the website design (multilingual contact page). Targets the embarrassment barrier and the anxiety that a medical inquiry will be mishandled or shared. Reduces friction for first-contact form submission. Particularly effective for the Sarah and Marcus personas who are researching in private. "Your privacy matters" is a conversion statement, not a platitude.


28

Google Ads Concepts

Campaign Type Headline 1 Headline 2 Headline 3 Description Landing Page
Treatment-intent Hemorrhoid Treatment Seattle 10-Minute Procedure, Same Day Published 5-Year Outcomes Near-zero pain. Back to work same or next day. Learn if you're a candidate for the FAST procedure. Procedure overview page
Comparison Not Ready for Surgery? Grade III Hemorrhoid Alternative One Visit. Lasting Results. 92% of 248 patients reported zero pain. Published results. Board-certified physicians. Procedure comparison page
Symptom-intent Hemorrhoids Won't Go Away? Creams Stopped Working? Modern Treatment Option A 10-minute minimally invasive option. Published 5-year outcomes for 248 patients. Seattle clinic. FAQ / symptom education page
Physician-referred patient Referred by Your Doctor? The FAST Procedure — Seattle Peer-Reviewed Outcomes Your physician referred you here. Learn what to expect and see published data for 248 patients. Dedicated physician referral landing page
Google Ads Concepts
Treatment-intent
Headline 1Hemorrhoid Treatment Seattle
Headline 210-Minute Procedure, Same Day
Headline 3Published 5-Year Outcomes
DescriptionNear-zero pain. Back to work same or next day. Learn if you're a candidate for the FAST procedure.
Landing PageProcedure overview page
Comparison
Headline 1Not Ready for Surgery?
Headline 2Grade III Hemorrhoid Alternative
Headline 3One Visit. Lasting Results.
Description92% of 248 patients reported zero pain. Published results. Board-certified physicians.
Landing PageProcedure comparison page
Symptom-intent
Headline 1Hemorrhoids Won't Go Away?
Headline 2Creams Stopped Working?
Headline 3Modern Treatment Option
DescriptionA 10-minute minimally invasive option. Published 5-year outcomes for 248 patients. Seattle clinic.
Landing PageFAQ / symptom education page
Physician-referred patient
Headline 1Referred by Your Doctor?
Headline 2The FAST Procedure — Seattle
Headline 3Peer-Reviewed Outcomes
DescriptionYour physician referred you here. Learn what to expect and see published data for 248 patients.
Landing PageDedicated physician referral landing page
29

Meta Ad Concepts

Concept Format Hook Primary Audience Guardrail
"The Gap" awareness Static carousel "Between ointments and surgery, there's a 10-minute option." Seattle 35–65, health/wellness interest No health condition targeting
Physician story Video (30 seconds) Named physician explains why they developed a better approach to a common condition Lookalike from website consultation form visitors Must disclose paid/promoted relationship
Outcome education Single image "92% of patients reported zero pain" with full study citation visible Seattle 35–65, general health interest Must cite Sias & Milone 2025 visibly in creative
FAQ-format video Short-form (60s) "3 questions patients ask before their first FAST appointment" Retargeting — website visitors who did not convert No diagnosis advice; "individual results may vary"
Meta Ad Concepts
"The Gap" awareness
FormatStatic carousel
Hook"Between ointments and surgery, there's a 10-minute option."
Primary AudienceSeattle 35–65, health/wellness interest
GuardrailNo health condition targeting
Physician story
FormatVideo (30 seconds)
HookNamed physician explains why they developed a better approach to a common condition
Primary AudienceLookalike from website consultation form visitors
GuardrailMust disclose paid/promoted relationship
Outcome education
FormatSingle image
Hook"92% of patients reported zero pain" with full study citation visible
Primary AudienceSeattle 35–65, general health interest
GuardrailMust cite Sias & Milone 2025 visibly in creative
FAQ-format video
FormatShort-form (60s)
Hook"3 questions patients ask before their first FAST appointment"
Primary AudienceRetargeting — website visitors who did not convert
GuardrailNo diagnosis advice; "individual results may vary"

Act VI

Launch Roadmap

30

Platform Status and Priority

Platform Role Current Status Priority Owner Target Launch Week
Website (FAST brand) Conversion endpoint for all traffic Figma design only — not built P0 — gates everything Amanda + dev team Weeks 1–4
Google Analytics 4 Attribution, optimization, audience building Not installed P0 — Day 1 of website Amanda With website
Google Business Profile Local search, map pack, reviews Not set up P0 — before clinic opens Amanda Weeks 1–2
Google Ads — Seattle Primary patient acquisition channel Not running P0 — Week 4 Amanda + MH1 Weeks 4–6
CRM (HubSpot / Zoho) Patient pipeline, lead management Not set up P0 — before first lead arrives Amanda Weeks 2–3
Call tracking (CallRail) Attribution + call recording for HIPAA compliance Not set up P1 — must launch with Google Ads Amanda Week 4
Email / SMS (Klaviyo / HubSpot) Lead nurture, post-procedure care, review requests Not set up P1 — Month 2 Amanda + MH1 Month 2
Meta Ads Awareness campaigns, retargeting Not set up P2 — Month 3 Amanda + MH1 Month 3
SEO content production Long-term organic patient acquisition Not started P1 — start immediately Amanda + writer Ongoing from now
Healthgrades / RealSelf Review platform presence Not set up P2 Amanda Month 1
Influencer / KOL program Awareness + social proof List exists (Amanda) P3 — Month 4 Amanda + MH1 Month 4
Platform Status and Priority
Website (FAST brand)
RoleConversion endpoint for all traffic
Current StatusFigma design only — not built
PriorityP0 — gates everything
OwnerAmanda + dev team
Target Launch WeekWeeks 1–4
Google Analytics 4
RoleAttribution, optimization, audience building
Current StatusNot installed
PriorityP0 — Day 1 of website
OwnerAmanda
Target Launch WeekWith website
Google Business Profile
RoleLocal search, map pack, reviews
Current StatusNot set up
PriorityP0 — before clinic opens
OwnerAmanda
Target Launch WeekWeeks 1–2
Google Ads — Seattle
RolePrimary patient acquisition channel
Current StatusNot running
PriorityP0 — Week 4
OwnerAmanda + MH1
Target Launch WeekWeeks 4–6
CRM (HubSpot / Zoho)
RolePatient pipeline, lead management
Current StatusNot set up
PriorityP0 — before first lead arrives
OwnerAmanda
Target Launch WeekWeeks 2–3
Call tracking (CallRail)
RoleAttribution + call recording for HIPAA compliance
Current StatusNot set up
PriorityP1 — must launch with Google Ads
OwnerAmanda
Target Launch WeekWeek 4
Email / SMS (Klaviyo / HubSpot)
RoleLead nurture, post-procedure care, review requests
Current StatusNot set up
PriorityP1 — Month 2
OwnerAmanda + MH1
Target Launch WeekMonth 2
Meta Ads
RoleAwareness campaigns, retargeting
Current StatusNot set up
PriorityP2 — Month 3
OwnerAmanda + MH1
Target Launch WeekMonth 3
SEO content production
RoleLong-term organic patient acquisition
Current StatusNot started
PriorityP1 — start immediately
OwnerAmanda + writer
Target Launch WeekOngoing from now
Healthgrades / RealSelf
RoleReview platform presence
Current StatusNot set up
PriorityP2
OwnerAmanda
Target Launch WeekMonth 1
Influencer / KOL program
RoleAwareness + social proof
Current StatusList exists (Amanda)
PriorityP3 — Month 4
OwnerAmanda + MH1
Target Launch WeekMonth 4

1

Days 1–30: Foundation — Build What Everything Else Depends On

Launch the FAST website: procedure overview page, consultation request form (HIPAA-compliant), clinical evidence section with link to published study, Seattle location and hours page, physician bio page for named providers, and an FAQ addressing cost, recovery, candidacy, and insurance. GA4 conversion tracking live from Day 1 — not as an afterthought. Schema markup on all relevant medical content pages (MedicalProcedure, MedicalClinic, Physician, FAQPage). Set up Google Business Profile with a complete listing, booking link connected to the consultation form, and first 4 educational posts scheduled. Implement CRM to capture and track every lead from the first one. Begin SEO content production immediately — content being published now will be indexed and ranking by September 2026. There is no "starting early" for SEO. There is only "not starting late." So What: Without a live, properly tracked website with a functioning consultation form, no marketing spend has a destination. This month gates every future dollar in the funnel. Nothing else in this plan matters until this is done.

2

Days 30–60: Demand Capture — Turn on the Acquisition Engine

Launch Google Ads in Seattle geo targeting three campaign types: treatment-intent (highest priority), symptom-based (volume), and comparison queries (quality). Starting budget $5K–$10K/month. Target CPL below $150 at launch. Begin physician outreach: identify the top 50 GI, internal medicine, and colorectal surgery practices within 30 miles of the Seattle clinic; Gareth begins in-person visits with referral packet, published study, and patient selection criteria. Set up CallRail for call tracking and HIPAA-compliant call recording. Launch email nurture sequence — minimum 3 emails for every new consultation request lead (intro + clinical evidence + FAQ/objection handling). Set up Healthgrades and RealSelf clinic profiles with complete information. So What: First leads arrive. First consultation requests come in. This is when real data starts to exist — CPL, form fill rate, lead quality, conversion rate. Every week without data is a week without optimization material.

3

Days 60–90: Conversion — Optimize the Funnel End to End

A/B test landing pages systematically: form placement vs. headline variants vs. CTA language vs. social proof elements. Optimize Google Ads by keyword performance, ad group, device type, and time-of-day bidding adjustments. Launch retargeting campaigns for website visitors who did not convert (30-day audience window) on Google Display and Meta. From the first treated patient: activate the review capture program — automated Day 7 and Day 30 post-procedure text and email with a Google review link. Begin planning the Meta awareness campaign for Month 3. Review physician referral pipeline: which physicians are sending patients? Double the outreach contact frequency with the active ones. Deprioritize those who are not responding after two contact attempts. So What: The Seattle clinic is approaching opening. Every conversion optimization decision made in this 30-day window will compound directly into Year 1 revenue. CPL should be trending toward $120 by the end of Month 3. If it is not, diagnose why before adding more budget.

4

Months 3–6: Scale — Compound the Channels That Are Working

Launch Meta awareness campaign at $2K–$5K/month. SEO content begins generating organic traffic by Month 4–5 if production started in April. Review velocity compounds — target 20+ Google reviews by Month 6 (critical for GBP local pack ranking). Physician referral program at 5+ active referring physicians generating consistent monthly referral volume. Launch influencer and KOL pilot with 1–2 medical professional KOLs identified from Amanda's list (FTC disclosure in every post, all content reviewed against guardrails.md before publication). Begin building email segmentation logic to serve different nurture sequences to Marcus, Sarah, and Robert personas based on inquiry language and source. So What: By Month 6, the acquisition engine should be multi-channel with compounding organic and referral volume supplementing paid search. CPL should be approaching $100–$120. Monthly procedures should be approaching 40–60 (50% of base capacity). This is the baseline that Year 1 revenue projections depend on. ---

31

North Star KPI: Monthly Procedures Completed

Milestone Target
Month 1 5–10 (soft launch ramp)
Month 3 20–30 (early momentum established)
Month 6 40–60 (50% capacity utilization)
Month 12 80–100 (75% capacity utilization)
North Star KPI: Monthly Procedures Completed
Month 15–10 (soft launch ramp)
Month 320–30 (early momentum established)
Month 640–60 (50% capacity utilization)
Month 1280–100 (75% capacity utilization)
32

Full KPI Dashboard

KPI Definition Month 3 Target Month 12 Target Owner
Monthly procedures completed Completed TSH procedures 20–30 80–100 Gareth + clinical
Monthly revenue Procedures × $4,000 avg $80K–$120K $320K–$400K Gareth
Patient Acquisition Cost (PAC) Total spend / procedures completed <$800 <$500 Amanda + MH1
Cost per Lead (CPL) Ad spend / total leads <$150 <$100 Amanda + MH1
Lead → Consultation rate Leads → booked consultations >55% >65% Amanda + clinical
Consultation → Procedure rate Booked → completed procedures >40% >50% Clinical + Amanda
Website monthly sessions Unique visitors 500–1,000 2,000–3,000 Amanda
Landing page CVR Visitors → form / call leads >8% >12% Amanda + MH1
Google Business Profile rating GBP star rating 4.5+ 4.7+ Amanda + clinical
Active physician referrals/month Monthly referral volume from physicians 5–10 20–30 Gareth
Review velocity New Google reviews per month 3–5 8–12 Amanda + clinical
Net Promoter Score (NPS) Post-procedure patient satisfaction survey >70 >75 Clinical team
Full KPI Dashboard
Monthly procedures completed
DefinitionCompleted TSH procedures
Month 3 Target20–30
Month 12 Target80–100
OwnerGareth + clinical
Monthly revenue
DefinitionProcedures × $4,000 avg
Month 3 Target$80K–$120K
Month 12 Target$320K–$400K
OwnerGareth
Patient Acquisition Cost (PAC)
DefinitionTotal spend / procedures completed
Month 3 Target<$800
Month 12 Target<$500
OwnerAmanda + MH1
Cost per Lead (CPL)
DefinitionAd spend / total leads
Month 3 Target<$150
Month 12 Target<$100
OwnerAmanda + MH1
Lead → Consultation rate
DefinitionLeads → booked consultations
Month 3 Target>55%
Month 12 Target>65%
OwnerAmanda + clinical
Consultation → Procedure rate
DefinitionBooked → completed procedures
Month 3 Target>40%
Month 12 Target>50%
OwnerClinical + Amanda
Website monthly sessions
DefinitionUnique visitors
Month 3 Target500–1,000
Month 12 Target2,000–3,000
OwnerAmanda
Landing page CVR
DefinitionVisitors → form / call leads
Month 3 Target>8%
Month 12 Target>12%
OwnerAmanda + MH1
Google Business Profile rating
DefinitionGBP star rating
Month 3 Target4.5+
Month 12 Target4.7+
OwnerAmanda + clinical
Active physician referrals/month
DefinitionMonthly referral volume from physicians
Month 3 Target5–10
Month 12 Target20–30
OwnerGareth
Review velocity
DefinitionNew Google reviews per month
Month 3 Target3–5
Month 12 Target8–12
OwnerAmanda + clinical
Net Promoter Score (NPS)
DefinitionPost-procedure patient satisfaction survey
Month 3 Target>70
Month 12 Target>75
OwnerClinical team
33

Scenario Analysis

Scenario Key Assumptions Month 12 Procedures Month 12 Revenue Year 1 Total Revenue
Conservative CPL $150, slow ramp, no active physician referral channel 40–50/mo $160K–$200K $1.0–1.4M
Base CPL $120, 50% utilization maturity, 5 active referring physicians 80–100/mo $320K–$400K $2.9M
Optimized CPL $100, 75% utilization, 10 active referring physicians, review velocity compounding 110–130/mo $440K–$520K $4.2–4.8M
Scenario Analysis
Conservative
Key AssumptionsCPL $150, slow ramp, no active physician referral channel
Month 12 Procedures40–50/mo
Month 12 Revenue$160K–$200K
Year 1 Total Revenue$1.0–1.4M
Base
Key AssumptionsCPL $120, 50% utilization maturity, 5 active referring physicians
Month 12 Procedures80–100/mo
Month 12 Revenue$320K–$400K
Year 1 Total Revenue$2.9M
Optimized
Key AssumptionsCPL $100, 75% utilization, 10 active referring physicians, review velocity compounding
Month 12 Procedures110–130/mo
Month 12 Revenue$440K–$520K
Year 1 Total Revenue$4.2–4.8M

Prepared by MH1 Growth Team | April 2026 Source: Sias F, Milone L (2025) "Thermal Submucosal Hemorrhoidopexy." J Surg 10:11513. DOI: 10.29011/2575-9760.011513 All clinical claims in this document reference the published case series. Evidence level: Level IV (retrospective case series, single center). Controlled trials pending (Paris and NYC, H2 2026). All patient-facing content derived from this document must be reviewed against guardrails.md before production or distribution.

Back to top